Geode Capital Management, LLC Coherus Bio Sciences, Inc. Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,741,226 shares of CHRS stock, worth $3.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,741,226
Previous 2,676,476 2.42%
Holding current value
$3.26 Million
Previous $1.95 Million 130.16%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$0.75 - $1.7 $48,562 - $110,075
64,750 Added 2.42%
2,741,226 $4.5 Million
Q2 2025

Aug 08, 2025
BUY
$0.72 - $1.12 $15,102 - $23,493
20,976 Added 0.79%
2,676,476 $1.95 Million
Q1 2025

May 13, 2025
BUY
$0.81 - $1.66 $45,247 - $92,729
55,861 Added 2.15%
2,655,500 $2.15 Million
Q4 2024

Feb 12, 2025
BUY
$0.67 - $1.71 $23,110 - $58,984
34,494 Added 1.34%
2,599,639 $3.59 Million
Q3 2024

Nov 12, 2024
BUY
$0.99 - $1.8 $181,084 - $329,245
182,914 Added 7.68%
2,565,145 $2.67 Million
Q2 2024

Aug 09, 2024
BUY
$1.58 - $2.51 $282,088 - $448,127
178,537 Added 8.1%
2,382,231 $4.12 Million
Q1 2024

May 13, 2024
BUY
$2.02 - $3.14 $246,627 - $383,372
122,093 Added 5.87%
2,203,694 $5.27 Million
Q4 2023

Feb 13, 2024
BUY
$1.59 - $3.85 $217,248 - $526,040
136,634 Added 7.03%
2,081,601 $6.93 Million
Q3 2023

Nov 13, 2023
BUY
$3.74 - $5.45 $1.96 Million - $2.86 Million
524,359 Added 36.91%
1,944,967 $7.27 Million
Q2 2023

Aug 11, 2023
BUY
$3.79 - $8.3 $425,382 - $931,575
112,238 Added 8.58%
1,420,608 $6.07 Million
Q1 2023

May 15, 2023
BUY
$5.89 - $10.52 $282,425 - $504,434
47,950 Added 3.8%
1,308,370 $8.95 Million
Q4 2022

Feb 13, 2023
BUY
$5.69 - $10.07 $177,590 - $314,294
31,211 Added 2.54%
1,260,420 $9.98 Million
Q3 2022

Nov 14, 2022
BUY
$7.17 - $13.87 $231,999 - $448,791
32,357 Added 2.7%
1,229,209 $11.8 Million
Q2 2022

Aug 12, 2022
BUY
$5.86 - $13.23 $168,744 - $380,971
28,796 Added 2.47%
1,196,852 $8.67 Million
Q1 2022

May 13, 2022
SELL
$10.92 - $16.41 $291,607 - $438,212
-26,704 Reduced 2.24%
1,168,056 $15.1 Million
Q4 2021

Feb 11, 2022
SELL
$15.81 - $18.99 $47,809 - $57,425
-3,024 Reduced 0.25%
1,194,760 $19.1 Million
Q3 2021

Nov 12, 2021
BUY
$12.68 - $17.79 $180,258 - $252,902
14,216 Added 1.2%
1,197,784 $19.2 Million
Q2 2021

Aug 13, 2021
BUY
$12.95 - $15.41 $1.09 Million - $1.3 Million
84,257 Added 7.66%
1,183,568 $16.4 Million
Q1 2021

May 12, 2021
BUY
$14.42 - $21.39 $1.61 Million - $2.39 Million
111,841 Added 11.33%
1,099,311 $16.1 Million
Q4 2020

Feb 12, 2021
BUY
$16.56 - $18.94 $487,029 - $557,025
29,410 Added 3.07%
987,470 $17.2 Million
Q3 2020

Nov 13, 2020
BUY
$17.41 - $19.89 $53,988 - $61,678
3,101 Added 0.32%
958,060 $17.6 Million
Q2 2020

Aug 13, 2020
SELL
$14.43 - $19.16 $202,351 - $268,680
-14,023 Reduced 1.45%
954,959 $17.1 Million
Q1 2020

May 14, 2020
BUY
$11.67 - $22.53 $873,336 - $1.69 Million
74,836 Added 8.37%
968,982 $15.7 Million
Q4 2019

Feb 13, 2020
BUY
$16.33 - $21.37 $613,632 - $803,020
37,577 Added 4.39%
894,146 $16.1 Million
Q3 2019

Nov 12, 2019
BUY
$16.3 - $23.37 $1.07 Million - $1.53 Million
65,606 Added 8.29%
856,569 $17.4 Million
Q2 2019

Aug 14, 2019
BUY
$13.1 - $22.1 $1.23 Million - $2.08 Million
93,978 Added 13.48%
790,963 $17.5 Million
Q1 2019

May 14, 2019
BUY
$8.38 - $15.5 $557,353 - $1.03 Million
66,510 Added 10.55%
696,985 $9.51 Million
Q4 2018

Feb 13, 2019
SELL
$8.65 - $16.28 $46,182 - $86,918
-5,339 Reduced 0.84%
630,475 $5.71 Million
Q3 2018

Nov 13, 2018
BUY
$14.45 - $20.25 $1.86 Million - $2.6 Million
128,389 Added 25.3%
635,814 $10.5 Million
Q2 2018

Aug 14, 2018
BUY
$10.25 - $17.45 $728,744 - $1.24 Million
71,097 Added 16.29%
507,425 $7.1 Million
Q1 2018

May 15, 2018
BUY
$9.1 - $13.7 $430,566 - $648,215
47,315 Added 12.16%
436,328 $4.82 Million
Q4 2017

Feb 13, 2018
BUY
$8.35 - $14.4 $80,335 - $138,542
9,621 Added 2.54%
389,013 $3.42 Million
Q3 2017

Nov 14, 2017
BUY
$11.1 - $14.5 $624,552 - $815,857
56,266 Added 17.41%
379,392 $5.06 Million
Q2 2017

Aug 14, 2017
BUY
N/A
323,126
323,126 $4.64 Million

Others Institutions Holding CHRS

# of Institutions
124
Shares Held
54.7M
Call Options Held
291K
Put Options Held
120K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $92.5M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email